임상 영양 시장 : 예측(2025-2030년)

The Clinical Nutrition Market will surge from USD 58.788 billion in 2025 to USD 89.338 billion by 2030, registering a 8.73% CAGR.

The clinical nutrition market is experiencing significant growth, driven by the increasing need to address nutritional deficiencies and metabolic disorders through specialized products. These products, including vitamins, proteins, minerals, and dietary supplements, are designed to maintain nutritional balance in patients, particularly those with chronic conditions. Since 2023, the market has been propelled by rising incidences of metabolic disorders such as diabetes and cancer, alongside growing malnutrition and obesity rates. The aging global population, particularly susceptible to metabolic and nutritional challenges, further fuels demand for clinical nutrition solutions.

Clinical nutrition encompasses a range of products, including parenteral and enteral nutrition, which require government approval due to their therapeutic applications, and medical foods used for nutritional support, which do not need regulatory clearance. These products are critical in managing conditions like malnutrition, metabolic disorders, and other health challenges by providing tailored nutritional support. Key growth drivers include the increasing prevalence of chronic diseases, which necessitate specialized nutritional interventions, and the rising global burden of malnutrition, particularly in regions with limited access to adequate diets. The geriatric population's vulnerability to nutritional deficiencies also drives market expansion, as clinical nutrition products address age-related metabolic challenges.

However, the market faces restraints, including stringent regulatory frameworks governing therapeutic nutrition products, which can delay product launches and increase compliance costs. Additionally, limited awareness of clinical nutrition's benefits among consumers and healthcare providers hinders adoption. The lack of advanced analytical technologies to fully validate nutritional deficiencies also poses challenges, as it limits the precision of tailored nutrition solutions.

Geographically, North America and Europe hold significant market shares, driven by advanced healthcare systems and high awareness of clinical nutrition's role in patient care. Asia-Pacific is emerging as a key growth region, fueled by rising healthcare investments and increasing chronic disease prevalence. Regulatory policies, particularly in developed markets, shape product development, with stringent standards ensuring safety and efficacy but also increasing operational complexities for manufacturers.

Competitive intelligence highlights major players such as B. Braun Melsungen AG, Stepan Company, Nestle Health Science, Baxter, Abbott, Filament BioSolutions Inc., NUTRICIA, Fresenius Kabi, Mead Johnson Nutrition Company, and Perrigo Nutritionals. These companies are investing in innovation to develop advanced nutritional formulations and expand their market presence through strategic partnerships. Market analysis, derived from industry reports and stakeholder inputs, employs bottom-up and top-down approaches to forecast demand, supply, and sales trends. Data triangulation ensures accurate insights, with charts and graphs enhancing stakeholder understanding.

From 2023 to 2025, the clinical nutrition market is poised for robust growth, driven by rising health challenges, an aging population, and increasing demand for specialized nutritional solutions. Regulatory hurdles and awareness gaps remain challenges, but ongoing innovations and expanding healthcare access position the market for sustained expansion.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Product Type

• Enteral Nutrition
• Parenteral Nutrition
• Infant Nutrition
• Medical Foods
• Supplements

By Route of Administration

• Oral
• Enteral
• Parental

By Therapeutic Area

• Oncology
• Metabolic Diseases
• Gastrointestinal (GI) Diseases
• Neurological Disorders
• Chronic Kidney Disease
• Pediatric and Neonatal
• Critical Care & Surgery Recovery
• Others

By User Type

• Pediatric
• Adult
• Geriatric

By End-User

• Hospitals & Clinics
• Homecare Settings
• Long-term Care Facilities
• Outpatient Specialty Centers

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Others
• Middle East & Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. CLINICAL NUTRITION MARKET BY PRODUCT TYPE

• 5.1. Introduction
• 5.2. Enteral Nutrition
• 5.3. Parenteral Nutrition
• 5.4. Infant Nutrition
• 5.5. Medical Foods
• 5.6. Supplements

6. CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION

• 6.1. Introduction
• 6.2. Oral
• 6.3. Enteral
• 6.4. Parental

7. CLINICAL NUTRITION MARKET BY THERAPEUTIC AREA

• 7.1. Introduction
• 7.2. Oncology
• 7.3. Metabolic Diseases
• 7.4. Gastrointestinal (Gi) Diseases
• 7.5. Neurological Disorders
• 7.6. Chronic Kidney Disease
• 7.7. Pediatric and Neonatal
• 7.8. Critical Care & Surgery Recovery
• 7.9. Others

8. CLINICAL NUTRITION MARKET BY USER TYPE

• 8.1. Introduction
• 8.2. Pediatric
• 8.3. Adult
• 8.4. Geriatric

9. CLINICAL NUTRITION MARKET BY END-USER

• 9.1. Introduction
• 9.2. Hospitals & Clinics
• 9.3. Homecare Settings
• 9.4. Long-term Care Facilities
• 9.5. Outpatient Specialty Centers

10. CLINICAL NUTRITION MARKET BY GEOGRAPHY

• 10.1. Introduction
• 10.2. North America
  • 10.2.1. By Product Type
  • 10.2.2. By Route of Administration
  • 10.2.3. By Therapeutic Area
  • 10.2.4. By User Type
  • 10.2.5. By End-User
  • 10.2.6. By Country
    • 10.2.6.1. United States
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. South America
  • 10.3.1. By Product Type
  • 10.3.2. By Route of Administration
  • 10.3.3. By Therapeutic Area
  • 10.3.4. By User Type
  • 10.3.5. By End-User
  • 10.3.6. By Country
    • 10.3.6.1. Brazil
    • 10.3.6.2. Argentina
    • 10.3.6.3. Others
• 10.4. Europe
  • 10.4.1. By Product Type
  • 10.4.2. By Route of Administration
  • 10.4.3. By Therapeutic Area
  • 10.4.4. By User Type
  • 10.4.5. By End-User
  • 10.4.6. By Country
    • 10.4.6.1. United Kingdom
    • 10.4.6.2. Germany
    • 10.4.6.3. France
    • 10.4.6.4. Italy
    • 10.4.6.5. Others
• 10.5. Middle East & Africa
  • 10.5.1. By Product Type
  • 10.5.2. By Route of Administration
  • 10.5.3. By Therapeutic Area
  • 10.5.4. By User Type
  • 10.5.5. By End-User
  • 10.5.6. By Country
    • 10.5.6.1. Saudi Arabia
    • 10.5.6.2. UAE
    • 10.5.6.3. Others
• 10.6. Asia Pacific
  • 10.6.1. By Product Type
  • 10.6.2. By Route of Administration
  • 10.6.3. By Therapeutic Area
  • 10.6.4. By User Type
  • 10.6.5. By End-User
  • 10.6.6. By Country
    • 10.6.6.1. Japan
    • 10.6.6.2. China
    • 10.6.6.3. India
    • 10.6.6.4. South Korea
    • 10.6.6.5. Taiwan
    • 10.6.6.6. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 11.1. Major Players and Strategy Analysis
• 11.2. Market Share Analysis
• 11.3. Mergers, Acquisitions, Agreements, and Collaborations
• 11.4. Competitive Dashboard

12. COMPANY PROFILES

• 12.1. B. Braun Melsungen AG
• 12.2. Stepan Company
• 12.3. Nestle Health Science
• 12.4. Baxter International Inc.
• 12.5. Abbott
• 12.6. Filament BioSolutions Inc.
• 12.7. Danone S.A.
• 12.8. Fresenius Kabi AG
• 12.9. Mead Johnson Nutrition Company (Reckitt Benckiser Group Plc)
• 12.10. Perrigo Nutritionals
• 12.11. Pfizer
• 12.12. Dsm-Firmenich
• 12.13. Ajinomoto

13. RESEARCH METHODOLOGY